D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$1.2B |
| 2 |
Boston Scientific
BSX
|
+$1.05B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$934M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$924M |
| 5 |
JPMorgan Chase
JPM
|
+$922M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.2B |
| 2 |
NVIDIA
NVDA
|
+$1.58B |
| 3 |
Palantir
PLTR
|
+$901M |
| 4 |
Netflix
NFLX
|
+$883M |
| 5 |
iShares Core S&P 500 ETF
IVV
|
+$805M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 30.42% |
| 2 | Technology | 18.55% |
| 3 | Consumer Discretionary | 8.97% |
| 4 | Financials | 8.5% |
| 5 | Healthcare | 8.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
IPCXR
4326
DELISTED
Inflection Point Acquisition Corp III Rights
IPCXR
| $7.75K | ﹤0.01% |
25,000
| – | – |
2025 Q2
3 quarters
|
|
4327
Fifth Era Acquisition Corp I Rights
FERAR
| $7.63K | ﹤0.01% |
27,143
| – | – |
2025 Q2
3 quarters
|
|
4328
Envoy Medical Warrant
COCHW
| $7.53K | ﹤0.01% |
113,431
| – | – |
2021 Q2
19 quarters
|
|
4329
Fusemachines Inc Warrants
FUSEW
$229K
| $7.5K | ﹤0.01% |
99,999
| – | – |
2025 Q4
1 quarter
|
|
|
SPKLW
4330
DELISTED
Spark I Acquisition Corp Warrant
SPKLW
| $7.31K | ﹤0.01% |
40,596
| – | – |
2023 Q4
9 quarters
|
|
4331
BARK
BARK
$72.4M
| $7.25K | ﹤0.01% |
716
-5,314
| -88% | -$81.6K |
2024 Q1
8 quarters
|
|
4332
Apollomics Inc Warrant
APLMW
| $6.37K | ﹤0.01% |
318,530
| – | – |
2023 Q1
12 quarters
|
|
4333
Estrella Immunopharma Warrant
ESLAW
| $6.13K | ﹤0.01% |
87,500
| – | – |
2021 Q3
18 quarters
|
|
4334
Coincheck Group Warrant expiring 12/10/2029
CNCKW
$802K
| $6.11K | ﹤0.01% |
21,831
| – | – |
2024 Q4
5 quarters
|
|
4335
Lotus Technology Inc Warrants
LOTWW
$27.8M
| $5.89K | ﹤0.01% |
117,840
| – | – |
2024 Q1
8 quarters
|
|
4336
SHF Holdings Warrants
SHFSW
$123K
| $5.64K | ﹤0.01% |
188,000
| – | – |
2023 Q1
12 quarters
|
|
|
CYCUW
4337
Cycurion Inc Warrant
CYCUW
$205K
| $5.15K | ﹤0.01% |
250,000
| – | – |
2022 Q2
15 quarters
|
|
4338
Zeo Energy Corp Warrants
ZEOWW
$155K
| $5.14K | ﹤0.01% |
125,000
| – | – |
2021 Q4
17 quarters
|
|
|
VEEAW
4339
Veea Inc Warrant
VEEAW
$631K
| $4.85K | ﹤0.01% |
90,749
| – | – |
2021 Q2
19 quarters
|
|
4340
DELISTED
GDEV Inc Warrant
GDEVW
| $4.77K | ﹤0.01% |
575,000
| – | – |
2021 Q3
18 quarters
|
|
4341
Pagaya Technologies Ltd Warrants
PGYWW
$576K
| $4.77K | ﹤0.01% |
107,225
| – | – |
2022 Q2
15 quarters
|
|
|
RNWWW
4342
DELISTED
ReNew Energy Global PLC Warrant
RNWWW
| $4.56K | ﹤0.01% |
591,955
| – | – |
2022 Q1
16 quarters
|
|
4343
CID HoldCo Inc Warrants
DAICW
$157K
| $4.12K | ﹤0.01% |
199,999
| – | – |
2025 Q2
3 quarters
|
|
4344
EUDA Health Holdings Warrant
EUDAW
$202K
| $4.08K | ﹤0.01% |
200,000
| – | – |
2022 Q1
16 quarters
|
|
4345
NET Power Inc Warrants
NPWR.WS
$13.1M
| $4.06K | ﹤0.01% |
15,032
| – | – |
2023 Q2
11 quarters
|
|
4346
SMX (Security Matters) Public Ltd Warrant
SMXWW
$678K
| $3.85K | ﹤0.01% |
79,166
| – | – |
2023 Q1
12 quarters
|
|
|
WGSWW
4347
DELISTED
GeneDx Holdings Warrant
WGSWW
| $3.74K | ﹤0.01% |
467,197
| – | – |
2021 Q1
20 quarters
|
|
4348
DELISTED
Talkspace Inc Warrant
TALKW
| $3.71K | ﹤0.01% |
1,059,485
| – | – |
2020 Q3
22 quarters
|
|
4349
DELISTED
Palladyne AI Corp Warrants
PDYNW
| $3.68K | ﹤0.01% |
58,622
| – | – |
2022 Q3
14 quarters
|
|
|
NIVFW
4350
NewGenIvf Group Warrants
NIVFW
$101K
| $3.34K | ﹤0.01% |
168,750
| – | – |
2024 Q2
7 quarters
|
|
Similar funds
D.E. Shaw & Co's Q1 2026 Portfolio in Review
As of Q1 2026, D.E. Shaw & Co held 5,226 positions worth $166B, down 8.8% from $182B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
D.E. Shaw & Co withdrew a net $5.92B in Q1 2026, closing 756 positions and reducing 1,922 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $805M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, down from 36% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, D.E. Shaw & Co opened a new position in Venture Global Inc worth $211M.
- D.E. Shaw & Co's largest Q1 2026 buy was Venture Global Inc: 13,410,074 shares worth $211M.
- D.E. Shaw & Co added most to Broadcom in Q1 2026, an estimated $1.2B increase.
- D.E. Shaw & Co's biggest Q1 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $3.2B.
- D.E. Shaw & Co fully exited iShares Core S&P 500 ETF in Q1 2026, selling an estimated $805M.
- D.E. Shaw & Co's ten largest holdings make up 11% of its $166B portfolio in Q1 2026.
- D.E. Shaw & Co opened 685 new positions and closed 756 in Q1 2026.
- D.E. Shaw & Co's portfolio value fell 8.8% quarter-over-quarter to $166B.
Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.